Human umbilical cord-derived mesenchymal stem cell therapy (Saiyi Biotech)

人脐带间充质干细胞（赛亿生物）

Report date: 2026/03/20 20:03:07

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Saiyi Biotech)
Drug Alias NameSY-001SY001 (Celyee)SY-001 (Celyee)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Saiyi Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Saiyi Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A